245 related articles for article (PubMed ID: 17908946)
1. Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.
Chau TT; Campbell JI; Galindo CM; Van Minh Hoang N; Diep TS; Nga TT; Van Vinh Chau N; Tuan PQ; Page AL; Ochiai RL; Schultsz C; Wain J; Bhutta ZA; Parry CM; Bhattacharya SK; Dutta S; Agtini M; Dong B; Honghui Y; Anh DD; Canh DG; Naheed A; Albert MJ; Phetsouvanh R; Newton PN; Basnyat B; Arjyal A; La TT; Rang NN; Phuong LT; Van Be Bay P; von Seidlein L; Dougan G; Clemens JD; Vinh H; Hien TT; Chinh NT; Acosta CJ; Farrar J; Dolecek C
Antimicrob Agents Chemother; 2007 Dec; 51(12):4315-23. PubMed ID: 17908946
[TBL] [Abstract][Full Text] [Related]
2. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
[TBL] [Abstract][Full Text] [Related]
3. Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
Nathania I; Nainggolan IM; Yasmon A; Nusatia ACM; Tjoa E; Gunardi WD; Moehario LH
BMC Microbiol; 2022 Oct; 22(1):250. PubMed ID: 36253712
[TBL] [Abstract][Full Text] [Related]
4. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
5. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
[TBL] [Abstract][Full Text] [Related]
6. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A.
Hirose K; Hashimoto A; Tamura K; Kawamura Y; Ezaki T; Sagara H; Watanabe H
Antimicrob Agents Chemother; 2002 Oct; 46(10):3249-52. PubMed ID: 12234852
[TBL] [Abstract][Full Text] [Related]
7. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
[TBL] [Abstract][Full Text] [Related]
9. Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy.
García-Fernández A; Gallina S; Owczarek S; Dionisi AM; Benedetti I; Decastelli L; Luzzi I
PLoS One; 2015; 10(6):e0132065. PubMed ID: 26121266
[TBL] [Abstract][Full Text] [Related]
10. Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.
Parry CM; Thuy CT; Dongol S; Karkey A; Vinh H; Chinh NT; Duy PT; Thieu Nga TV; Campbell JI; Van Minh Hoang N; Arjyal A; Bhutta ZA; Bhattacharya SK; Agtini MD; Dong B; Canh DG; Naheed A; Wain J; Tinh Hien T; Basnyat B; Ochiai L; Clemens J; Farrar JJ; Dolecek C; Baker S
Antimicrob Agents Chemother; 2010 Dec; 54(12):5201-8. PubMed ID: 20837759
[TBL] [Abstract][Full Text] [Related]
11. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
[No Abstract] [Full Text] [Related]
12. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
14. Molecular evaluation of drug resistance in clinical isolates of Salmonella enterica serovar Typhi from Pakistan.
Afzal A; Sarwar Y; Ali A; Maqbool A; Salman M; Habeeb MA; Haque A
J Infect Dev Ctries; 2013 Dec; 7(12):929-40. PubMed ID: 24334939
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling of antimicrobial resistance genes in clinical isolates of Salmonella Typhi from patients infected with Typhoid fever in India.
Katiyar A; Sharma P; Dahiya S; Singh H; Kapil A; Kaur P
Sci Rep; 2020 May; 10(1):8299. PubMed ID: 32427945
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance in Salmonella enterica Serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam.
Chiou CS; Lauderdale TL; Phung DC; Watanabe H; Kuo JC; Wang PJ; Liu YY; Liang SY; Chen PC
Antimicrob Agents Chemother; 2014 Nov; 58(11):6501-7. PubMed ID: 25136011
[TBL] [Abstract][Full Text] [Related]
17. A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A.
Song Y; Roumagnac P; Weill FX; Wain J; Dolecek C; Mazzoni CJ; Holt KE; Achtman M
J Antimicrob Chemother; 2010 Aug; 65(8):1631-41. PubMed ID: 20511368
[TBL] [Abstract][Full Text] [Related]
18. Screening method for Salmonella enterica serovar Typhi and serovar Paratyphi A with reduced susceptibility to fluoroquinolones by PCR-restriction fragment length polymorphism.
Hirose K; Tamura K; Watanabe H
Microbiol Immunol; 2003; 47(2):161-5. PubMed ID: 12680720
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal.
Acharya D; Trakulsomboon S; Madhup SK; Korbsrisate S
Jpn J Infect Dis; 2012; 65(3):264-7. PubMed ID: 22627312
[TBL] [Abstract][Full Text] [Related]
20. Emergence of an Extensively Drug-Resistant
Klemm EJ; Shakoor S; Page AJ; Qamar FN; Judge K; Saeed DK; Wong VK; Dallman TJ; Nair S; Baker S; Shaheen G; Qureshi S; Yousafzai MT; Saleem MK; Hasan Z; Dougan G; Hasan R
mBio; 2018 Feb; 9(1):. PubMed ID: 29463654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
